Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Authors Forest Laboratories -More
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
Links ClinicalTrials.gov
An outpatient study to evaluate the safety and efficacy of cariprazine as adjunct to antidepressant therapy (ADT) in participants with major depressive disorder (MDD) who have an inadequate response to ADT alone. This clinical study compared cariprazine + ADT with placebo + ADT in outpatients with a diagnosis of MDD and an inadequate response to ADT. The study consisted of approximately 2 weeks of screening and washout followed by 8 weeks of double-blind treatment followed by a 1 week safety follow-up.
Epistemonikos ID: 005e8cf9599eae9e1e24cff0d17a5d07776ee007
First added on: May 10, 2024